Vascular Function at Baseline in the Hemodialysis Fistula Maturation Study

Background End‐stage renal disease is accompanied by functional and structural vascular abnormalities. The objective of this study was to characterize vascular function in a large cohort of patients with end‐stage renal disease, using noninvasive physiological measurements, and to correlate function with demographic and clinical factors. Methods and Results We analyzed cross‐sectional baseline data from the Hemodialysis Fistula Maturation Study, a multicenter prospective observational cohort study of 602 patients with end‐stage renal disease from 7 centers. Brachial artery flow‐ and nitroglycerin‐mediated dilation, carotid‐femoral and ‐radial pulse wave velocity, and venous occlusion plethysmography were performed prior to arteriovenous fistula creation. Relationships of these vascular function measures with demographic, clinical, and laboratory factors were evaluated using linear mixed‐effects models. Arterial function, as assessed by flow‐ and nitroglycerin‐mediated dilation and carotid‐femoral pulse wave velocity, worsened with increasing age and diabetes mellitus. Venous capacitance decreased with diabetes mellitus but not with age. Flow‐mediated dilation was higher among patients undergoing maintenance dialysis than for those at predialysis, and a U‐shaped relationship between serum phosphorus concentration and flow‐mediated dilation was evident. Partial correlations among different measures of vascular function, adjusting for demographic factors, diabetes mellitus, and clinical center, were modest or essentially nonexistent. Conclusions Multiple demographic and clinical factors were associated with the functions of vessels of different sizes and types in this large cohort of patients with end‐stage renal disease. Low correlations between the different measures, controlling for demographic factors, diabetes mellitus, and center, indicated that these different types of vascular function otherwise vary heterogeneously across patients.

[1]  D. Levy,et al.  Changes in Arterial Stiffness and Wave Reflection With Advancing Age in Healthy Men and Women: The Framingham Heart Study , 2004, Hypertension.

[2]  G. Beck,et al.  Objectives and design of the hemodialysis fistula maturation study. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[3]  A. Batterham,et al.  The percentage flow-mediated dilation index: A large-sample investigation of its appropriateness, potential for bias and causal nexus in vascular medicine , 2013, Vascular medicine.

[4]  M. Safar,et al.  Stiffness of Capacitive and Conduit Arteries: Prognostic Significance for End-Stage Renal Disease Patients , 2005, Hypertension.

[5]  C. Zoccali,et al.  Longitudinal Analysis of Vascular Function and Biomarkers of Metabolic Bone Disorders before and after Renal Transplantation , 2013, American Journal of Nephrology.

[6]  D. Thijssen,et al.  A new approach to improve the specificity of flow-mediated dilation for indicating endothelial function in cardiovascular research. , 2013, Journal of hypertension.

[7]  J. Blacher,et al.  Aortic pulse wave velocity index and mortality in end-stage renal disease. , 2003, Kidney international.

[8]  G. Mitchell Effects of central arterial aging on the structure and function of the peripheral vasculature: implications for end-organ damage. , 2008, Journal of applied physiology.

[9]  G. London,et al.  Local shear stress and brachial artery functions in end-stage renal disease. , 2007, Journal of the American Society of Nephrology : JASN.

[10]  Increased arterial stiffness in Europeans and African Caribbeans with type 2 diabetes cannot be accounted for by conventional cardiovascular risk factors. , 2006, American journal of hypertension.

[11]  Yoav Ben-Shlomo,et al.  Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects. , 2014, Journal of the American College of Cardiology.

[12]  M. Creager,et al.  -.____----.---_-Impaired Nitric Oxide-Mediated Vasodilation in Patients With Non-Insulin-Dependent Diabetes Mellitw , 2016 .

[13]  M. Allon,et al.  Impact of obesity on arteriovenous fistula outcomes in dialysis patients. , 2007, Kidney international.

[14]  J. Blacher,et al.  Impact of Aortic Stiffness Attenuation on Survival of Patients in End-Stage Renal Failure , 2001, Circulation.

[15]  J. Loscalzo,et al.  Effects of Race and Hypertension on Flow-Mediated and Nitroglycerin-Mediated Dilation of the Brachial Artery , 2001, Hypertension.

[16]  M. Marmot,et al.  Adiposity, obesity, and arterial aging: longitudinal study of aortic stiffness in the Whitehall II cohort (vol 66, pg 294, 2015) , 2015 .

[17]  Alik Farber,et al.  Peripheral artery disease is associated with severe impairment of vascular function , 2013, Vascular medicine.

[18]  N. Tangri,et al.  Non-invasive endothelial function testing and the risk of adverse outcomes: a systematic review and meta-analysis. , 2014, European heart journal cardiovascular Imaging.

[19]  S. Kaya,et al.  Malnutrition-inflammation score and endothelial dysfunction in hemodialysis patients. , 2010, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

[20]  M. McKee,et al.  Phosphate regulation of vascular smooth muscle cell calcification. , 2000, Circulation research.

[21]  T. Iwasaka,et al.  Prognostic Significance of Ankle-Brachial Index, Brachial-Ankle Pulse Wave Velocity, Flow-Mediated Dilation, and Nitroglycerin-Mediated Dilation in End-Stage Renal Disease , 2009, American Journal of Nephrology.

[22]  Michael J. Pencina,et al.  Arterial Stiffness and Cardiovascular Events: The Framingham Heart Study , 2010, Circulation.

[23]  W. Riley,et al.  Brachial Flow-Mediated Vasodilator Responses in Population-Based Research: Methods, Reproducibility and Effects of Age, Gender and Baseline Diameter , 2001, Journal of cardiovascular risk.

[24]  R. Schnabel,et al.  Noninvasive Vascular Function Measurement in the Community: Cross-Sectional Relations and Comparison of Methods , 2011, Circulation. Cardiovascular imaging.

[25]  J. Floege,et al.  Vascular calcification in patients with end-stage renal disease. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[26]  E. Benjamin,et al.  Clinical Correlates and Heritability of Flow-Mediated Dilation in the Community: The Framingham Heart Study , 2004, Circulation.

[27]  P. Blankestijn,et al.  Forearm venous distensibility predicts successful arteriovenous fistula. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[28]  H. Young,et al.  Obesity as a Predictor of Vascular Access Outcomes: Analysis of the USRDS DMMS Wave II Study , 2008, Seminars in dialysis.

[29]  A. Batterham,et al.  Allometric scaling of diameter change in the original flow-mediated dilation protocol. , 2013, Atherosclerosis.

[30]  G. D. Johnston,et al.  Impaired endothelium-dependent and independent vasodilation in patients with Type 2 (non-insulin-dependent) diabetes mellitus , 1992, Diabetologia.

[31]  D. Webb,et al.  Venous occlusion plethysmography in cardiovascular research: methodology and clinical applications. , 2001, British journal of clinical pharmacology.

[32]  J. Kaski,et al.  Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease--a cross-sectional study of predialysis, dialysis and kidney-transplantation patients. , 2011, Atherosclerosis.